TWO MORE VACCINES AND A DRUG JOIN INDIA’S FIGHT AGAINST COVID-19 #New covid vaccine #aprroved
India has approved two more vaccines under emergency use authorisation and an antiviral drug , Molnupiravir . Currently, India uses Covishield, Covaxin and Sputnik V in its vaccination programme. Corbevax to be made by Hyderabad-based Biological-E is a protein sub-unit vaccine and Covovax, to be manufactured by Serum Institute of India. Corbevax is co-developed by Biological E, Baylor College of Medicine in Houston, United States, and American company Dynavax Technologies. Covovax is produced by the Serum Institute of India under licence from Novavax, a U.S.-based biotechnology company. Covovax has been approved by the World Health Organisation (WHO) under its Emergency Use Listing and, therefore, will also be available globally as part of the COVAX initiative to ensure that at least 40% of world is vaccinated on priority. Molnupiravir , that was approved this month by the U.S. Food and Drugs Administration (U.S. FDA), on the heels of Paxlovid by Pfizer Inc , is said...